News Approved - Relatix Health

May 5, 2026

TUBSIS 2.0 – Tobacco Use Behavioral Support and Intervention System

Conditions: Tobacco Use Disorder; Nicotine Dependence; Vaping; Smoking Tobacco

Interventions: Behavioral: TUBSIS 2.0

Sponsors: University of Zurich; State Secretariat for Education Research and Innovation, Switzerland

Recruiting

May 5, 2026

The Effectiveness of 4-STEP-Training Program for Social Media Addiction (4-STEP-TPS) and Psychological Problems Among Adolescence

Conditions: 4-STEP-Training Program for Social Media Addiction

Interventions: Behavioral: 4-STEP-Training Program for Social Media Addiction (4-STEP-TPS)

Sponsors: Government College University Faisalabad

Not yet recruiting

May 5, 2026

PrevED MR. Improving Emotion Dysregulation Through Mixed Reality Based Dialectical Behavioral Therapy in Adolescents and Young Adults at Risk of Developing Eating Disorders.

Conditions: Eating Disorders; Emotion Dysregulation

Interventions: Behavioral: PrevED MR Intervention

Sponsors: Universitat Internacional de Catalunya; Ministerio de Ciencia e Innovación, Spain

Not yet recruiting

May 5, 2026

Optimization of Late Imagery Rescripting Research Using Generative Artificial Intelligence

Conditions: Generalized Anxiety; Fear of Failure; Rumination

Interventions: Behavioral: Imagery Rescripting Intervention

Sponsors: University of Social Sciences and Humanities, Warsaw

Recruiting

May 5, 2026

Two-week Intensive Outpatient Trauma Treatment.

Conditions: Posttraumatic Stress Disorder (PTSD)

Interventions: Other: Prolonged exposure and EMDR

Sponsors: Oslo University Hospital

Recruiting

May 5, 2026

KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn Injury

Conditions: PTSD and Trauma-related Symptoms

Interventions: Behavioral: Preparatory Session; Drug: Ketamine-assisted Psychotherapy Session #1; Drug: Ketamine-assisted Psychotherapy Session #2; Behavioral: Integration Session

Sponsors: Irma Fleming; University of Utah

Not yet recruiting

May 5, 2026

Group Retreat Psilocybin Therapy for Healthcare Clinicians With Loss of Meaning in Their Work and Symptoms of Depression

Conditions: Depression; Anxiety

Interventions: Drug: Psilocybin

Sponsors: University of Washington

Not yet recruiting

May 5, 2026

Coaching as an Adjunct to Ketamine Therapy for Treatment-Resistant Depression

Conditions: Treatment Resistant Depression (TRD)

Interventions: Behavioral: Psychedelic Integration Coaching

Sponsors: Massachusetts General Hospital; Fireside Project

Recruiting

May 5, 2026

Group PACBT for Depression

Conditions: Depression – Major Depressive Disorder; Psilocybin; Cognitive Behavioral Therapy

Interventions: Drug: Psilocybin (drug); Behavioral: Group Cognitive Behavioral Therapy

Sponsors: University of California, Los Angeles

Not yet recruiting

May 5, 2026

Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications

Conditions: Negative Symptoms of Schizophrenia

Interventions: Drug: Roluperidone; Drug: risperidone; Drug: aripiprazole; Drug: olanzapine; Drug: Placebo

Sponsors: Minerva Neurosciences

Recruiting